News

Deal Announcements

Exosome Diagnostics Closes $20 Million Series A

Thursday, May 13, 2010 5:29:00 AM PDT | VentureDeal Staff
New York, New York  --  Biotechnology diagnostics company Exosome Diagnostics has secured $20 million in its first round of venture capital investment.

Exosome is developing what it calls a next-generation body fluid-based oncology diagnostics platform.

NGN Capital and Forbion Capital Partners co-led the round.  The company said it would use the funding to further develop and commercialize its platform.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1